Academic Editor: Michael H. Dahan
The authors wish to make the following corrections to this paper [1]:
(1) The authors would like to add the 3 scholars to the list of authorship. And the newly added authors is responsible for the collection data of the paper. The corrected author information is provide below:
Sureyya Saridas Demir
(2) The authors would like to clarify that Turner syndrome is equivalent to monosomy X(Turner syndrome = monosomy X), So the author made the following changes in the full text:
① Replace Table 2 with the table below.
| Age Range | 30–34 | 35–39 | Total | ||
| Central nervous system anomalies | 28 | 35 | 10 | 6 | 79 |
| PPROM ( |
21 | 11 | 6 | 4 | 42 |
| Multiple fetal anomalies | 8 | 11 | 4 | 4 | 27 |
| Anhydramnios (without congenital anomalies) | 7 | 10 | 3 | 1 | 21 |
| Cardiovascular system anomalies | 9 | 7 | 2 | 2 | 20 |
| Genitourinary system anomalies | 8 | 4 | 1 | 1 | 14 |
| Musculoskeletal system anomalies | 7 | 4 | 2 | 1 | 14 |
| Cystic Hygroma | 3 | 2 | 1 | 6 | |
| Hydrops Fetalis | 2 | 2 | 1 | 5 | |
| Thoracic anomalies | 1 | 1 | 2 | ||
| Use of X group drugs (methotrexate etc.) during pregnancy | 1 | 2 | 2 | 5 | |
| Maternal Advanced stage malignancies | 1 | 1 | 2 | ||
| Maternal Cardiovascular and Renal diseases | 1 | 1 | |||
| Maternal Congenital metabolic liver diseases | 1 | 1 | |||
| Maternal fetal infections | 1 | 1 | |||
| Trisomy 21 | 6 | 10 | 12 | 11 | 39 |
| Trisomy 18 | 2 | 5 | 3 | 6 | 16 |
| Triploidy | 1 | 3 | 1 | 5 | |
| Turner syndrome | 3 | 2 | 2 | 7 | |
| Trisomy 13 | 1 | 2 | 3 | ||
| Triple X syndrome | 1 | 1 | 2 | ||
| Duchene muscular dystrophy | 1 | 1 | |||
| Fragile X syndrome | 1 | 1 | |||
| Di George syndrome | 1 | 1 | |||
| Partial trisomy 3 | 1 | 1 | |||
| Partial 4p deletion | 1 | 1 | |||
| Partial trisomy 18 | 1 | 1 | |||
| Total n (%) | 111 (34.9 %) | 116 (36.4%) | 53 (16.6%) | 38 (11.9%) | 318 |
| Note: PPROM, Preterm premature rupture of membrane. | |||||
② Replace Table 4 with the table below.
| Number of patients | Percentage | |
| Chromosomal disorders | ||
| Trisomy 21 | 39 | 12.3% |
| Trisomy 18 | 16 | 5% |
| Turner syndrome | 7 | 2.2% |
| Triploidy | 5 | 1.6% |
| Trisomy 13 | 3 | 0.9% |
| Triple X syndrome | 2 | 0.6% |
| Duchenne muscular dystrophy | 1 | 0.3% |
| Fragile X syndrome | 1 | 0.3% |
| Di George syndrome | 1 | 0.3% |
| Partial trisomy 3 | 1 | 0.3% |
| Partial 4p deletion | 1 | 0.3% |
| Partial trisomy 18 | 1 | 0.3% |
| Total | 78 |
③ The original “Turner syndrome in 1.3%” in the first line in the right column of the 87 page is replaced by “Turner syndrome in 2.2 %”.
(3) The authors would like to re-clarify the author’s contribution, the corrected author’s contribution are provided below:
SSD, EC, SA designed the article. SSD, TC, EB, DE collected the data SSD analyzed the data and wrote the article. All authors contributed to editorial changes to the article. All authors have read and approved the final version of the article before publication.